October 22, 2018
Via: medicaldevice-network.comThe approval has labelled HeartMate 3 as a destination therapy for people who are not eligible for a transplant. LVADs are designed to pump blood through the body in order to significantly cut down the workload on a weakened heart. […]
July 19, 2024
Copyright © 2024. All rights reserved
